// COMPANY
Personalis
SECTOR BIOTECHMENTIONS 1LAST SEEN JULY 21, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
m_and_a·Lucinda Shen·JULY 21, 2026
“Tempus AI (Nasdaq: TEM) agreed to buy Personalis (Nasdaq: PSNL), a Fremont, Calif.-based cancer genomics company, for $1.7b.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.